Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Mantle Cell Lymphoma
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Condition:
B-cell Malignancies, Mantle cell lymphoma, and Multiple Myeloma
Journal:
Frontiers in immunology
Treatment Used:
CAR T-Cell Therapy
Number of Patients:
0
Published —
March 01, 2021
This article discusses the use of CAR T-cell therapy in the treatment of patients with B-cell malignancies, mantle cell lymphoma, and multiple myeloma.
Condition:
Mantle Cell Lymphoma
Journal:
The Permanente journal
Treatment Used:
Concurrent Radiotherapy and Lenalidomide
Number of Patients:
1
Published —
January 23, 2021
In this study, researchers evaluated the safety and effectiveness of adding lenalidomide to radiotherapy for the treatment of mantle cell lymphoma.
Condition:
Mantle Cell Lymphoma
Journal:
Current oncology (Toronto, Ont.)
Treatment Used:
Rituximab
Number of Patients:
NULL
Published —
December 31, 2020
The study researched the outcomes of treatment for mantle cell lymphoma.
Condition:
Mantle Cell Lymphoma
Journal:
The Lancet. Haematology
Treatment Used:
Lenalidomide Maintenance After Autologous Hematopoietic Stem Cell Transplantation (HSCT)
Number of Patients:
303
Published —
December 28, 2020
This study investigated whether lenalidomide maintenance improves progression-free survival after autologous hematopoietic stem cell transplantation (replacement of a recipient’s bone marrow with donor hematopoietic stem cells; HSCT) in patients with mantle cell lymphoma (cancer of white blood cells).
Condition:
Mantle Cell Lymphoma
Journal:
[Rinsho ketsueki] The Japanese journal of clinical hematology
Treatment Used:
Ibrutinib
Number of Patients:
1
Published —
November 09, 2020
The study researched a case of mantle cell lymphoma.
Condition:
Relapsed/Refractory Mantle Cell Lymphoma
Journal:
Drugs of today (Barcelona, Spain : 1998)
Treatment Used:
Zanubrutinib
Number of Patients:
118
Published —
October 07, 2020
The study researched the outcomes of Zanubrutinib for treating relapsed/refractory mantle cell lymphoma.
Condition:
Mantle Cell Lymphoma
Journal:
Blood advances
Treatment Used:
Bendamustine and Rituximab as Induction Therapy
Number of Patients:
190
Published —
August 01, 2020
In this study, researchers evaluated the outcomes of using bendamustine and rituximab as induction therapy for the treatment of mantle cell lymphoma.
Condition:
Spontaneous Tumor Lysis Syndrome (SPTLS) in Blastoid-Variant Mantle Cell Lymphoma
Journal:
Journal of investigative medicine high impact case reports
Treatment Used:
Rasburicase
Number of Patients:
1
Published —
July 29, 2020
This case report describes a patient with blastoid-variant mantle cell lymphoma diagnosed with spontaneous tumor lysis syndrome (SPTLS).
Condition:
Relapse and Refractory Mantle Cell Lymphoma
Journal:
Annals of hematology
Treatment Used:
Temsirolimus in Combination with Three Different Immuno-Chemotherapy Regimens
Number of Patients:
41
Published —
July 01, 2020
This study investigated the recommended dose of temsirolimus in association with R-CHOP (R-CHOP-T), or high-dose cytarabine plus rituximab (R-DHA-T), or fludarabine, cyclophosphamide plus rituximab (R-FC-T) in patients with relapse and refractory mantle cell lymphoma.
Condition:
Mantle Cell Lymphoma
Journal:
Terapevticheskii arkhiv
Treatment Used:
Adapted Intensive Induction Therapy, Autologous Stem Cell Transplantation, and Rituximab
Number of Patients:
47
Published —
June 30, 2020
The study researched the outcomes of adapted intensive induction therapy, autologous stem cell transplantation, and rituximab for treating mantle cell lymphoma.
Condition:
Mantle Cell Lymphoma
Journal:
Cancer cell
Treatment Used:
CAR T Cells
Number of Patients:
0
Published —
June 10, 2020
This article discusses the use of CAR T cells for the treatment of patients with mantle cell lymphoma.
Condition:
Relapsed or Refractory Mantle-Cell Lymphoma (MCL)
Journal:
Clinical cancer research : an official journal of the American Association for Cancer Research
Treatment Used:
Zanubrutinib
Number of Patients:
86
Published —
May 29, 2020
This study evaluated the safety and effectiveness of zanubrutinib in patients with relapsed or refractory mantle-cell lymphoma (MCL).
Showing 1-12 of 77
Next